CD133, but Not CD44, May Serve as a Novel Biomarker for Differential Diagnosis Between Basal Cell Carcinoma and Trichoblastomas

PURPOSE: To investigate the clinical value of CD133 and CD44 as putative cancer stem cell markers in distinguishing between basal cell carcinoma (BCC) and trichoblastomas (TB). PATIENTS AND METHODS: Tumor samples from 24 BCC and 23 TB patients were retrospectively retrieved for immunohistochemical s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yalan, Shi, Xiaohua, Chen, Dian, Zhao, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356750/
https://www.ncbi.nlm.nih.gov/pubmed/35941854
http://dx.doi.org/10.2147/CCID.S373331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356750/
https://www.ncbi.nlm.nih.gov/pubmed/35941854
http://dx.doi.org/10.2147/CCID.S373331

Ejemplares similares